Capmatinib is a pharmaceutical raw material that functions as a c-Met tyrosine kinase inhibitor. It is used in the manufacturing of research compounds for targeting cancers associated with MET gene mutations.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Capmatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Capmatinib dihydrochloride monohydrate
pharmaceutical raw material
Zelboraf
pharmaceutical raw material
Trelagliptin succinate
pharmaceutical raw material
Paracetamol
pharmaceutical raw material
(R)-(7-METHYL-1,4-DIAZEPAN-1-YL)(5-METHYL-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE
pharmaceutical raw material
The international HS code for Capmatinib (CAS 1029712-80-8) is 2933.49.
2933.49
2933 49 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide
LIOLIMKSCNQPLV-UHFFFAOYSA-N
CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F
Sourcing Capmatinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.